Published in Am J Med on October 15, 2002
Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev (2007) 15.66
Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis (2006) 1.89
Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care (2008) 1.49
Impact of invasive fungal infection on outcomes of severe sepsis: a multicenter matched cohort study in critically ill surgical patients. Crit Care (2008) 1.04
Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. Crit Care (2011) 1.03
Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in adult surgical cancer patients. Eur J Clin Microbiol Infect Dis (2004) 1.02
Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B. Crit Care (2009) 0.91
Clinical characteristics and risk factors for nosocomial candidemia in medical intensive care units: experience in a single hospital in Korea for 6.6 years. J Korean Med Sci (2010) 0.89
Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units. BMC Infect Dis (2016) 0.87
Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis. Crit Care (2012) 0.84
Estimating attributable mortality of candidemia: clinical judgement vs matched cohort studies. Eur J Clin Microbiol Infect Dis (2003) 0.83
Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature. Eur J Med Res (2011) 0.83
Invasive candidiasis in non-hematological patients. Mediterr J Hematol Infect Dis (2011) 0.83
Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection. BMC Infect Dis (2013) 0.80
Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study. Crit Care (2016) 0.80
Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts? Ther Clin Risk Manag (2008) 0.79
The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study. BMC Infect Dis (2014) 0.77
Assessment of the types of catheter infectivity caused by Candida species and their biofilm formation. First study in an intensive care unit in Algeria. Int J Gen Med (2013) 0.77
Initial antifungal strategy does not correlate with mortality in patients with candidemia. Eur J Clin Microbiol Infect Dis (2015) 0.77
Residual attributable mortality, a new concept for understanding the value of antibiotics in treating life-threatening acute infections. Antimicrob Agents Chemother (2010) 0.75
Temporal Trends of the Clinical, Resource Use and Outcome Attributes of ICU-Managed Candidemia Hospitalizations: A Population-Level Analysis. J Clin Med Res (2016) 0.75
Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med (2002) 3.28
Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol (2003) 3.16
Impact of real-time electronic alerting of acute kidney injury on therapeutic intervention and progression of RIFLE class. Crit Care Med (2012) 2.30
Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med (2003) 2.26
Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis (2005) 2.26
Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med (2005) 2.16
Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol Dial Transplant (2005) 1.72
Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit. Crit Care Med (2006) 1.71
Centers for Disease Control and Prevention guidelines for preventing central venous catheter-related infection: results of a knowledge test among 3405 European intensive care nurses. Crit Care Med (2009) 1.48
Outcome and changes over time in survival following severe burns from 1985 to 2004. Intensive Care Med (2005) 1.33
Outcome in noninvasively and invasively ventilated hematologic patients with acute respiratory failure. Chest (2004) 1.31
Effect of nosocomial bloodstream infection on the outcome of critically ill patients with acute renal failure treated with renal replacement therapy. J Am Soc Nephrol (2004) 1.25
Candida peritonitis. Curr Opin Crit Care (2007) 1.21
Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy. J Crit Care (2013) 1.20
Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. Nephrol Dial Transplant (2005) 1.18
Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung (2009) 1.14
Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol (2013) 1.03
Acute effects of upright position on gas exchange in patients with acute respiratory distress syndrome. J Intensive Care Med (2005) 0.98
Sodium bicarbonate versus THAM in ICU patients with mild metabolic acidosis. J Nephrol (2005) 0.97
Extrapancreatic inflammation on abdominal computed tomography as an early predictor of disease severity in acute pancreatitis: evaluation of a new scoring system. Pancreas (2007) 0.97
Adherence to and efficacy and safety of an insulin protocol in the critically ill: a prospective observational study. Am J Crit Care (2007) 0.96
Acute kidney injury in burns: a story of volume and inflammation. Crit Care (2008) 0.90
No early respiratory benefit with CVVHDF in patients with acute renal failure and acute lung injury. Nephrol Dial Transplant (2002) 0.90
Cardiorenal syndrome type 3: pathophysiologic and epidemiologic considerations. Contrib Nephrol (2013) 0.90
Evaluation of outcome in critically ill patients with nosocomial enterobacter bacteremia: results of a matched cohort study. Chest (2003) 0.89
Documented and clinically suspected bacterial infection precipitating intensive care unit admission in patients with hematological malignancies: impact on outcome. Intensive Care Med (2005) 0.88
Dynamics of C-reactive protein and white blood cell count in critically ill patients with nosocomial Gram positive vs. Gram negative bacteremia: a historical cohort study. BMC Infect Dis (2007) 0.86
Acute kidney injury in critically ill patients with cancer. Crit Care Clin (2010) 0.84
Nurses' knowledge of evidence-based guidelines for the prevention of surgical site infection. Worldviews Evid Based Nurs (2009) 0.81
Significant increase of activated partial thromboplastin time by heparinization of the radial artery catheter flush solution with a closed arterial catheter system. Crit Care Med (2002) 0.79
Education reduces ventilator-associated pneumonia rates. Clin Infect Dis (2008) 0.78
Medical imaging and timely diagnosis of invasive pulmonary aspergillosis. Clin Infect Dis (2006) 0.76
Invasive devices: no need? No use! Intensive Care Med (2006) 0.75
Trends in mortality in coronary artery bypass graft patients with acute renal failure. Crit Care Med (2008) 0.75
Would patients with more subtle signs of coagulopathy have benefited from treatment with activated protein C? Crit Care Med (2005) 0.75
Obstacles to implementing evidence-based guidelines. Respir Care (2008) 0.75
Estimates of attributable mortality of systemic candida infection in the ICU. J Crit Care (2003) 0.75
Invasive aspergillosis in immunocompetent patients. South Med J (2006) 0.75
Fluid vs. air for semicontinuous intra-abdominal pressure measurements using a compliance catheter. Intensive Care Med (2005) 0.75